Document is current
Any future updates will be listed below
-
Authors
Fan, Christopher
Kim, Ahyoung
Li, Sean
Naidoo, Jarushka
Cappelli, Laura C.
Brahmer, Julie R.
Anders, Robert A.
Kim, Amy K.
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH T32 GM06669)
National Institutes of Health (K08 CA237624)
U.S. Department of Defense (W81XWH-20-1-0605)
- License Information
-
More Information
Article History
Received: 11 July 2022
Accepted: 15 August 2022
First Online: 14 September 2022
Declarations
:
: CF is supported by an NIH T32 GM066691. JN is supported by Merck, Astrazeneca, BMS, Amgen, Novartis, Roche/Genentech and on the consulting/advisory board of: Merck, Astrazeneca, BMS, Amgen, Novartis, Roche/Genentech, Takeda, Pfizer, Daiichi Sankyo, NGM biosciences. LCC provides consulting and has research funding support from Bristol-Myers Squibb. JRB is an advisory board member of Amgen, BMS, Genentech, Eli Lilly, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, Regeneron and receives funding support from: AstraZeneca, BMS, Genentech, RAPT Therapeutics, Inc., Revolution Medicine and is a DSMB member of Sanofi, GlaxoSmithKline, Janssen. RAA is a consultant for Bristol Myers Squib. AKK is supported by NCI K08 CA237624 and DoD Award W81XWH-20-1-0605, Exelixis and AstraZeneca.
